![Aimee Kestranek](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Aimee Kestranek
Operationeel Directeur bij Cleveland Diagnostics, Inc.
Profiel
Aimee Kestranek is currently the Chief Operating Officer at Cleveland Diagnostics, Inc. Prior to this, she worked as the Vice President-Analytical Services at Analiza, Inc.
Actieve functies van Aimee Kestranek
Bedrijven | Functie | Begin |
---|---|---|
Cleveland Diagnostics, Inc.
![]() Cleveland Diagnostics, Inc. Investment Trusts/Mutual FundsMiscellaneous Cleveland Diagnostics, Inc. develops and commercializes cancer diagnostics and screening tests. Its portfolio of non-invasive cancer diagnostic tests includes blood-based tests to screen for prostate, breast, and ovarian cancer. The company was founded by Arnon Chait and Boris Zaslavsky in October 2013 and is headquartered in Cleveland, OH. | Operationeel Directeur | - |
Eerdere bekende functies van Aimee Kestranek
Bedrijven | Functie | Einde |
---|---|---|
Analiza, Inc.
![]() Analiza, Inc. Medical SpecialtiesHealth Technology Analiza, Inc. provides physicochemical services. Its services include solubility, chemical stability and accurate mass. Analiza was founded in 1996 and is headquartered in Cleveland, OH. | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Analiza, Inc.
![]() Analiza, Inc. Medical SpecialtiesHealth Technology Analiza, Inc. provides physicochemical services. Its services include solubility, chemical stability and accurate mass. Analiza was founded in 1996 and is headquartered in Cleveland, OH. | Health Technology |
Cleveland Diagnostics, Inc.
![]() Cleveland Diagnostics, Inc. Investment Trusts/Mutual FundsMiscellaneous Cleveland Diagnostics, Inc. develops and commercializes cancer diagnostics and screening tests. Its portfolio of non-invasive cancer diagnostic tests includes blood-based tests to screen for prostate, breast, and ovarian cancer. The company was founded by Arnon Chait and Boris Zaslavsky in October 2013 and is headquartered in Cleveland, OH. | Miscellaneous |